Treatment of trophoblastic tumours.
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy; D011247:Pregnancy; D011379:Prognosis; D014328:Trophoblastic Neoplasms / Q000601:surgery / Q000628:therapy*; D014594:Uterine Neoplasms / Q000601:surgery / Q000628:therapy*
D000970:Antineoplastic Agents